Bruhn T O, Jackson I M
Department of Medicine, Brown University/Rhode Island Hospital, Providence 02903.
Regul Pept. 1992 Apr 9;38(3):221-30. doi: 10.1016/0167-0115(92)90104-3.
Spontaneously hypertensive rats (SHR) are characterized by several neuroendocrine abnormalities including a chronic hypersecretion of thyrotropin (TSH) of unknown etiology. We hypothesized that the inappropriately high TSH secretion in SHR may be the result of an impaired thyroid hormone negative feedback regulation of hypothalamic thyrotropin-releasing hormone (TRH) and/or pituitary TSH production. To test this hypothesis, SHR or their normotensive Wistar-Kyoto (WKY) controls were treated with either methimazole (0.02% in drinking water) to induce hypothyroidism or administered L-thyroxine (T4) at a dose of 0.8 or 2.0 micrograms/100 g body weight/day to induce hyperthyroidism. All treatments were continued for 14 days after which animals were killed under low stress conditions. TSH concentrations in plasma and anterior pituitary tissue were 2-fold higher (P less than 0.01) in euthyroid SHR compared to WKY control rats while thyroid hormone (T3 and T4) levels were in the normal range. Hypothyroidism induced by either methimazole or thyroidectomy caused a significant (P less than 0.01) rise of plasma TSH levels in both WKY and SHR rats. However, relative to the TSH concentrations in control animals, the increase of plasma TSH in SHR was significantly blunted (P less than 0.01) in comparison to the WKY group. Hypothyroidism caused a significant depletion of TRH in stalk-median eminence (SME) tissue in both groups of rats. However, no differences between SHR and WKY rats were observed. The administration of thyroid hormone caused a dose dependent suppression of plasma TSH levels in both strains of rats. However, at both doses tested plasma TSH concentrations in SHR rats were significantly less suppressed (P less than 0.05) than those in WKY animals. Under in vitro conditions basal and potassium induced TRH release from SMEs derived from SHR was significantly (P less than 0.05) higher than that from WKY rats, whether expressed in absolute terms or as percent of content. These findings suggest that the thyroid hormone negative feedback regulation of TSH secretion may be impaired in SHR rats. Our data do not allow conclusions as to whether defects in the regulation of TSH production are located exclusively at the hypothalamic level. Since the overproduction of hypothalamic TRH and hypophysial TSH should lead to an increased thyroid hormone biosynthesis other defects in the hypothalamus-pituitary-thyroid-axis may contribute to the abnormal regulation of TSH secretion in SHR rats.
自发性高血压大鼠(SHR)具有多种神经内分泌异常特征,包括促甲状腺激素(TSH)慢性分泌过多,但其病因不明。我们推测,SHR中TSH分泌异常增高可能是由于甲状腺激素对下丘脑促甲状腺激素释放激素(TRH)和/或垂体TSH生成的负反馈调节受损所致。为验证这一假设,将SHR或其血压正常的Wistar-Kyoto(WKY)对照大鼠用甲巯咪唑(饮用水中含0.02%)治疗以诱导甲状腺功能减退,或按0.8或2.0微克/100克体重/天的剂量给予L-甲状腺素(T4)以诱导甲状腺功能亢进。所有治疗持续14天,之后在低应激条件下处死动物。与WKY对照大鼠相比,甲状腺功能正常的SHR血浆和垂体前叶组织中的TSH浓度高出2倍(P<0.01),而甲状腺激素(T3和T4)水平在正常范围内。甲巯咪唑或甲状腺切除诱导的甲状腺功能减退导致WKY和SHR大鼠血浆TSH水平显著升高(P<0.01)。然而,相对于对照动物中的TSH浓度,与WKY组相比,SHR中血浆TSH的升高明显减弱(P<0.01)。甲状腺功能减退导致两组大鼠的垂体柄-正中隆起(SME)组织中TRH显著减少。然而,未观察到SHR和WKY大鼠之间存在差异。给予甲状腺激素导致两种品系大鼠的血浆TSH水平呈剂量依赖性抑制。然而,在测试的两种剂量下,SHR大鼠的血浆TSH浓度受抑制程度均显著低于WKY动物(P<0.05)。在体外条件下,无论是以绝对值还是以含量百分比表示,源自SHR的SME中基础状态下和钾诱导的TRH释放均显著高于WKY大鼠(P<0.05)。这些发现表明,SHR大鼠中TSH分泌的甲状腺激素负反馈调节可能受损。我们的数据无法得出关于TSH生成调节缺陷是否仅位于下丘脑水平的结论。由于下丘脑TRH和垂体TSH过度生成应导致甲状腺激素生物合成增加,下丘脑-垂体-甲状腺轴中的其他缺陷可能导致SHR大鼠中TSH分泌的异常调节。